normative

Easier generic entry would slash prices like Poland's Gleevec

True market competition through easier generic entry would dramatically cut prices: with only one competitor a firm prices at about 90% of the original, but with many generics—like the 19 versions of Gleevec sold in Poland or store-brand Tylenol at Costco—prices fall sharply, so the U.S. should shorten monopoly protection, block Big Pharma from delaying generics, and ease entry from India, China and elsewhere.

normativepending

Speaker

Vincent Rajkumar

Evidence Quote

“what we need to do is encourage a lot of generic companies to come establish markets here, prevent pharma, Big Pharma, from introducing these generics”

Source

Vincent Rajkumar on the High Price of Cancer Drugs— EconTalk
Created: 6/13/2026, 12:13:30 AM

Your notes

Loading notes...